Trial intelligence / Profile preview

Micronized dHACM in Knee Osteoarthritis

NCT03485157Phase 2Completed

Sponsor
MIMEDX
Start
Mar 2018
Primary completion
Apr 2022
Modality
Implantable Devices, Implantable Hydrogels, Tissue Cells
Countries
1
01

Overview

A Phase 2 trial of AmnioFix in osteoarthritis (OA), sponsored by MIMEDX. Started Mar 2018; status: completed.

02

Drugs

AmnioFix
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT03485157.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03485157.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call